Tissue Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Description

List of Tables

GlobalData's Medical Devices sector report, "Tissue Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Tissue Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue Regenerative Material is a biomaterial component which facilitates regeneration of lost periodontal hard and soft tissue.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Tissue Regenerative Materials under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Tissue Regenerative Materials under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Product Code: GDME1384EPD

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Tissue Regenerative Materials Overview

3 Products under Development

3.1 Tissue Regenerative Materials - Pipeline Products by Stage of Development
3.2 Tissue Regenerative Materials - Pipeline Products by Territory
3.3 Tissue Regenerative Materials - Pipeline Products by Regulatory Path
3.4 Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
3.5 Tissue Regenerative Materials - Ongoing Clinical Trials

4 Tissue Regenerative Materials - Pipeline Products under Development by Companies

4.1 Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
4.2 Tissue Regenerative Materials - Pipeline Products by Stage of Development

5 Tissue Regenerative Materials Companies and Product Overview

5.1 Advanced Biotech Products Pvt Ltd Company Overview
5.2 Colorado Therapeutics, LLC Company Overview
5.3 credentis AG Company Overview
5.4 Histocell SL Company Overview
5.5 Indian Institute of Technology Bombay Company Overview
5.6 Maxigen Biotech Inc Company Overview
5.7 Medtronic Plc Company Overview
5.8 Nobel Biocare Services AG Company Overview
5.9 Novatissue SAS Company Overview
5.10 Orthocell Ltd Company Overview
5.11 Orthorebirth Co Ltd Company Overview
5.12 Polytechnic University of Catalonia Company Overview
5.13 Straumann Holding AG Company Overview
5.14 SurgaColl Technologies Ltd Company Overview
5.15 SweetBio, Inc. Company Overview
5.16 Tetratherix Pty Ltd Company Overview
5.17 Tigran Technologies AB Company Overview

6 Tissue Regenerative Materials- Recent Developments

6.1 May 26, 2022: CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
6.2 Apr 13, 2022: CollPlant To Present at the Aesthetics Innovation Summit 2022
6.3 Mar 24, 2022: CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results
6.4 Feb 15, 2022: Straumann Group reports revenue exceeding CHF 2 billion
6.5 Feb 04, 2022: Straumann Group announces invitation for 2021 full-year financial results webcast
6.6 Jan 25, 2022: Medprin Regenerative Medical Technologies Announces on the resignation of the company's director and board secretary
6.7 Jan 07, 2022: Collagen Matrix Names Tony Orsini Chief Operating Officer
6.8 Dec 21, 2021: Maipu Medical Announcement on Appointment of Deputy General Manager of the Company
6.9 Nov 18, 2021: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results
6.10 Oct 18, 2021: Straumann Group 2021 third-quarter financial results webcast invitation
6.11 Aug 19, 2021: CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results
6.12 Jul 29, 2021: Invitation: Straumann Group 2021 half-year financial results webcast
6.13 Jul 15, 2021: Christian Ullrich joins Straumann Group's Executive Management Board as the new Group Chief Information Officer

7 Appendix

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

Product Code: GDME1384EPD

List of Tables

Tissue Regenerative Materials - Pipeline Products by Stage of Development
Tissue Regenerative Materials - Pipeline Products by Territory
Tissue Regenerative Materials - Pipeline Products by Regulatory Path
Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
Tissue Regenerative Materials - Ongoing Clinical Trials
Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
Tissue Regenerative Materials - Pipeline Products by Stage of Development
Glossary

List of Figures

Tissue Regenerative Materials - Pipeline Products by Stage of Development
Tissue Regenerative Materials - Pipeline Products by Territory
Tissue Regenerative Materials - Pipeline Products by Regulatory Path
Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
Tissue Regenerative Materials - Ongoing Clinical Trials